BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
US Army
Johnson and Johnson

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202838

« Back to Dashboard

NDA 202838 describes DESOXIMETASONE, which is a drug marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising Pharms Inc, Altana, G And W Labs Inc, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. It is available from fourteen suppliers. Additional details are available on the DESOXIMETASONE profile page.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.
Summary for 202838
Pharmacology for NDA: 202838
Medical Subject Heading (MeSH) Categories for 202838
Suppliers and Packaging for NDA: 202838
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 202838 ANDA Glenmark Pharmaceuticals Inc., USA 68462-531 N 68462-531-65
DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 202838 ANDA Glenmark Pharmaceuticals Inc., USA 68462-531 N 68462-531-17

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.25%
Approval Date:Sep 20, 2013TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.